I know the market doesn’t seem to care atm, but I think we are in a better position than yesterday. It just reinforces in my mind that Cynata’s decision to do a rct in HR-agvhd is the right approach.
Furthermore, we are almost at a recruitment stage with 30 sites activating.
The trial is somewhat risky as it will be measuring efficacy of Cynata mscs against steroids (essentially SOC), but I guess that’s what you have to prove to be taken seriously anyway.
I know the market doesn’t seem to care atm, but I think we are...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
16.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $36.15M | |||
| Open | High | Low | Value | Volume |
| 16.0¢ | 16.0¢ | 16.0¢ | $1.021K | 6.379K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 77738 | 16.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 16.5¢ | 3400 | 1 |
View Market Depth
| Last trade - 09.59am 24/06/2025 (20 minute delay) ? |
| CYP (ASX) Chart |